List of Tables

Table 1. BCG and Tuberculosis Vaccine Consumption Value & CAGR: China VS Global, 2020-2031, US$ Million

Table 2. BCG and Tuberculosis Vaccine Market Restraints

Table 3. BCG and Tuberculosis Vaccine Market Trends

Table 4. BCG and Tuberculosis Vaccine Industry Policy

Table 5. Global BCG and Tuberculosis Vaccine Revenue by Company, 2020-2025, US$ million, Ranked Based on Revenue in 2024

Table 6. Global BCG and Tuberculosis Vaccine Revenue Share by Company, 2020-2025, Ranked by Data of 2024

Table 7. Global BCG and Tuberculosis Vaccine Sales Quantity by Company, (2020-2025) & (K Units), Ranked Based on Sales in 2024

Table 8. Global BCG and Tuberculosis Vaccine Sales Quantity by Company, 2020-2025, Ranked by Data of 2024

Table 9. Global BCG and Tuberculosis Vaccine Average Selling Price (ASP) by Company, (2020-2025) & (US$/Unit)

Table 10. Global BCG and Tuberculosis Vaccine Manufacturers Market Concentration Ratio (CR3 and HHI)

Table 11. Global BCG and Tuberculosis Vaccine Mergers & Acquisitions, Expansion Plans

Table 12. Global BCG and Tuberculosis Vaccine Manufacturers Product Type

Table 13. Head Office and BCG and Tuberculosis Vaccine Production Site of Key Manufacturer

Table 14. BCG and Tuberculosis Vaccine Capacity of Major Manufacturers and Future Plan

Table 15. China BCG and Tuberculosis Vaccine Revenue by Company, 2020-2025, US$ million, Ranked Based on Revenue in 2024

Table 16. China BCG and Tuberculosis Vaccine Revenue Share by Company, 2020-2025, Ranked by Data of 2024

Table 17. China BCG and Tuberculosis Vaccine Sales Quantity by Company, (2020-2025) & (K Units), Ranked Based on Sales in 2024

Table 18. China BCG and Tuberculosis Vaccine Sales Quantity by Company, 2020-2025, Ranked by Data of 2024

Table 19. Global BCG and Tuberculosis Vaccine Production & Forecast by Region, 2020 VS 2024 VS 2031, (K Units)

Table 20. Global BCG and Tuberculosis Vaccine Production by Region, 2020-2025, (K Units)

Table 21. Global BCG and Tuberculosis Vaccine Production Forecast by Region, 2026-2031, (K Units)

Table 22. Global Key Players of BCG and Tuberculosis Vaccine Upstream (Raw Materials)

Table 23. Global BCG and Tuberculosis Vaccine Typical Customers

Table 24. BCG and Tuberculosis Vaccine Typical Distributors

Table 25. by Type, Global BCG and Tuberculosis Vaccine Consumption Value & CAGR, 2020 VS 2024 VS 2031, US$ Million

Table 26. by Application, Global BCG and Tuberculosis Vaccine Consumption Value & CAGR, 2020 VS 2024 VS 2031, US$ Million

Table 27. By Region, Global BCG and Tuberculosis Vaccine Consumption Value, 2020 VS 2024 VS 2031, US$ Million

Table 28. By Region, Global BCG and Tuberculosis Vaccine Consumption Value, 2020-2031, US$ Million

Table 29. By Region, Global BCG and Tuberculosis Vaccine Sales Quantity, 2020-2031, (K Units)

Table 30. By Country, Global BCG and Tuberculosis Vaccine Consumption Value & CAGR, 2020 VS 2024 VS 2031, US$ Million

Table 31. By Country, Global BCG and Tuberculosis Vaccine Consumption Value, 2020-2031, US$ Million

Table 32. By Country, Global BCG and Tuberculosis Vaccine Consumption Value Market Share, 2020-2031

Table 33. By Country, Global BCG and Tuberculosis Vaccine Sales Quantity, 2020-2031, (K Units)

Table 34. By Country, Global BCG and Tuberculosis Vaccine Sales Quantity Market Share, 2020-2031

Table 35. Merck Company Information, Head Office, Market Area, and Industry Position

Table 36. Merck BCG and Tuberculosis Vaccine Models, Specifications, and Application

Table 37. Merck BCG and Tuberculosis Vaccine Sales Quantity (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2020-2025

Table 38. Merck Company Profile and Main Business

Table 39. Merck Recent Developments

Table 40. Japan BCG Lab Company Information, Head Office, Market Area, and Industry Position

Table 41. Japan BCG Lab BCG and Tuberculosis Vaccine Models, Specifications, and Application

Table 42. Japan BCG Lab BCG and Tuberculosis Vaccine Sales Quantity (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2020-2025

Table 43. Japan BCG Lab Company Profile and Main Business

Table 44. Japan BCG Lab Recent Developments

Table 45. Serum Institute of India Company Information, Head Office, Market Area, and Industry Position

Table 46. Serum Institute of India BCG and Tuberculosis Vaccine Models, Specifications, and Application

Table 47. Serum Institute of India BCG and Tuberculosis Vaccine Sales Quantity (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2020-2025

Table 48. Serum Institute of India Company Profile and Main Business

Table 49. Serum Institute of India Recent Developments

Table 50. AJ Vaccines Company Information, Head Office, Market Area, and Industry Position

Table 51. AJ Vaccines BCG and Tuberculosis Vaccine Models, Specifications, and Application

Table 52. AJ Vaccines BCG and Tuberculosis Vaccine Sales Quantity (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2020-2025

Table 53. AJ Vaccines Company Profile and Main Business

Table 54. AJ Vaccines Recent Developments

Table 55. BioFarma Company Information, Head Office, Market Area, and Industry Position

Table 56. BioFarma BCG and Tuberculosis Vaccine Models, Specifications, and Application

Table 57. BioFarma BCG and Tuberculosis Vaccine Sales Quantity (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2020-2025

Table 58. BioFarma Company Profile and Main Business

Table 59. BioFarma Recent Developments

Table 60. GreenSignal Bio Pharma Company Information, Head Office, Market Area, and Industry Position

Table 61. GreenSignal Bio Pharma BCG and Tuberculosis Vaccine Models, Specifications, and Application

Table 62. GreenSignal Bio Pharma BCG and Tuberculosis Vaccine Sales Quantity (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2020-2025

Table 63. GreenSignal Bio Pharma Company Profile and Main Business

Table 64. GreenSignal Bio Pharma Recent Developments

Table 65. China National Biotec Company Information, Head Office, Market Area, and Industry Position

Table 66. China National Biotec BCG and Tuberculosis Vaccine Models, Specifications, and Application

Table 67. China National Biotec BCG and Tuberculosis Vaccine Sales Quantity (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2020-2025

Table 68. China National Biotec Company Profile and Main Business

Table 69. China National Biotec Recent Developments

Table 70. Biomed Lublin Company Information, Head Office, Market Area, and Industry Position

Table 71. Biomed Lublin BCG and Tuberculosis Vaccine Models, Specifications, and Application

Table 72. Biomed Lublin BCG and Tuberculosis Vaccine Sales Quantity (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2020-2025

Table 73. Biomed Lublin Company Profile and Main Business

Table 74. Biomed Lublin Recent Developments

Table 75. Taj Pharmaceuticals Company Information, Head Office, Market Area, and Industry Position

Table 76. Taj Pharmaceuticals BCG and Tuberculosis Vaccine Models, Specifications, and Application

Table 77. Taj Pharmaceuticals BCG and Tuberculosis Vaccine Sales Quantity (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2020-2025

Table 78. Taj Pharmaceuticals Company Profile and Main Business

Table 79. Taj Pharmaceuticals Recent Developments

Table 80. Ataulpho de Paiva Company Information, Head Office, Market Area, and Industry Position

Table 81. Ataulpho de Paiva BCG and Tuberculosis Vaccine Models, Specifications, and Application

Table 82. Ataulpho de Paiva BCG and Tuberculosis Vaccine Sales Quantity (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2020-2025

Table 83. Ataulpho de Paiva Company Profile and Main Business

Table 84. Ataulpho de Paiva Recent Developments

Table 85. IVAC-Institute of Vaccines and Medical Biologicals Company Information, Head Office, Market Area, and Industry Position

Table 86. IVAC-Institute of Vaccines and Medical Biologicals BCG and Tuberculosis Vaccine Models, Specifications, and Application

Table 87. IVAC-Institute of Vaccines and Medical Biologicals BCG and Tuberculosis Vaccine Sales Quantity (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2020-2025

Table 88. IVAC-Institute of Vaccines and Medical Biologicals Company Profile and Main Business

Table 89. IVAC-Institute of Vaccines and Medical Biologicals Recent Developments

Table 90. Queen Saovabha Mem. Inst Company Information, Head Office, Market Area, and Industry Position

Table 91. Queen Saovabha Mem. Inst BCG and Tuberculosis Vaccine Models, Specifications, and Application

Table 92. Queen Saovabha Mem. Inst BCG and Tuberculosis Vaccine Sales Quantity (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2020-2025

Table 93. Queen Saovabha Mem. Inst Company Profile and Main Business

Table 94. Queen Saovabha Mem. Inst Recent Developments

Table 95. Microgen Company Information, Head Office, Market Area, and Industry Position

Table 96. Microgen BCG and Tuberculosis Vaccine Models, Specifications, and Application

Table 97. Microgen BCG and Tuberculosis Vaccine Sales Quantity (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2020-2025

Table 98. Microgen Company Profile and Main Business

Table 99. Microgen Recent Developments

List of Figures

Figure 1. BCG and Tuberculosis Vaccine Picture

Figure 2. Global BCG and Tuberculosis Vaccine Consumption Value, (US$ million) & (2020-2031)

Figure 3. Global BCG and Tuberculosis Vaccine Sales Quantity, (K Units) & (2020-2031)

Figure 4. Global BCG and Tuberculosis Vaccine Average Selling Price (ASP), (2020-2031) & (US$/Unit)

Figure 5. China BCG and Tuberculosis Vaccine Consumption Value, (US$ million) & (2020-2031)

Figure 6. China BCG and Tuberculosis Vaccine Sales Quantity (K Units) & (2020-2031)

Figure 7. China BCG and Tuberculosis Vaccine Average Selling Price (ASP), (US$/Unit) & (2020-2031)

Figure 8. By Consumption Value, China BCG and Tuberculosis Vaccine Market Share of Global, 2020-2031

Figure 9. By Sales Quantity, China BCG and Tuberculosis Vaccine Market Share of Global, 2020-2031

Figure 10. Global BCG and Tuberculosis Vaccine Market Share by Company, (Tier 1, Tier 2, and Tier 3), 2024

Figure 11. China BCG and Tuberculosis Vaccine Key Participants, Market Share, 2024

Figure 12. Global BCG and Tuberculosis Vaccine Capacity, Production and Capacity Utilization, 2020-2031

Figure 13. Global BCG and Tuberculosis Vaccine Capacity Market Share by Region, 2024 VS 2031

Figure 14. Global BCG and Tuberculosis Vaccine Production Market Share & Forecast by Region, 2020-2031

Figure 15. BCG and Tuberculosis Vaccine Industry Chain

Figure 16. BCG and Tuberculosis Vaccine Procurement Model

Figure 17. BCG and Tuberculosis Vaccine Sales Model

Figure 18. BCG and Tuberculosis Vaccine Sales Channels, Direct Sales, and Distribution

Figure 19. Immune Vaccine

Figure 20. Therapy Vaccine

Figure 21. by Type, Global BCG and Tuberculosis Vaccine Consumption Value, 2020-2031, US$ Million

Figure 22. by Type, Global BCG and Tuberculosis Vaccine Consumption Value Market Share, 2020-2031

Figure 23. by Type, Global BCG and Tuberculosis Vaccine Sales Quantity, 2020-2031, (K Units)

Figure 24. by Type, Global BCG and Tuberculosis Vaccine Sales Quantity Market Share, 2020-2031

Figure 25. by Type, Global BCG and Tuberculosis Vaccine Average Selling Price (ASP), 2020-2031, (US$/Unit)

Figure 26. Self-Procurement

Figure 27. UNICEF

Figure 28. Others

Figure 29. by Application, Global BCG and Tuberculosis Vaccine Consumption Value, 2020-2031, US$ Million

Figure 30. by Application, Global BCG and Tuberculosis Vaccine Revenue Market Share, 2020-2031

Figure 31. by Application, Global BCG and Tuberculosis Vaccine Sales Quantity, 2020-2031, (K Units)

Figure 32. by Application, Global BCG and Tuberculosis Vaccine Sales Quantity Market Share, 2020-2031

Figure 33. by Application, Global BCG and Tuberculosis Vaccine Price, 2020-2031, (US$/Unit)

Figure 34. By Region, Global BCG and Tuberculosis Vaccine Consumption Value Market Share, 2020-2031

Figure 35. By Region, Global BCG and Tuberculosis Vaccine Sales Quantity Market Share, 2020-2031

Figure 36. North America BCG and Tuberculosis Vaccine Consumption Value & Forecasts, 2020-2031, US$ Million

Figure 37. By Country, North America BCG and Tuberculosis Vaccine Consumption Value Market Share, 2024

Figure 38. Europe BCG and Tuberculosis Vaccine Consumption Value & Forecasts, 2020-2031, US$ Million

Figure 39. By Country, Europe BCG and Tuberculosis Vaccine Consumption Value Market Share, 2024

Figure 40. Asia Pacific BCG and Tuberculosis Vaccine Consumption Value & Forecasts, 2020-2031, US$ Million

Figure 41. By Country/Region, Asia Pacific BCG and Tuberculosis Vaccine Consumption Value Market Share, 2024

Figure 42. South America BCG and Tuberculosis Vaccine Consumption Value & Forecasts, 2020-2031, US$ Million

Figure 43. By Country, South America BCG and Tuberculosis Vaccine Consumption Value Market Share, 2024

Figure 44. Middle East & Africa BCG and Tuberculosis Vaccine Consumption Value & Forecasts, 2020-2031, US$ Million

Figure 45. United States BCG and Tuberculosis Vaccine Sales Quantity, 2020-2031, (K Units)

Figure 46. by Type, United States BCG and Tuberculosis Vaccine Sales Quantity Market Share, 2024 VS 2031

Figure 47. by Application, United States BCG and Tuberculosis Vaccine Sales Quantity Market Share, 2024 VS 2031

Figure 48. Europe BCG and Tuberculosis Vaccine Sales Quantity, 2020-2031, (K Units)

Figure 49. by Type, Europe BCG and Tuberculosis Vaccine Sales Quantity Market Share, 2024 VS 2031

Figure 50. by Application, Europe BCG and Tuberculosis Vaccine Sales Quantity Market Share, 2024 VS 2031

Figure 51. China BCG and Tuberculosis Vaccine Sales Quantity, 2020-2031, (K Units)

Figure 52. by Type, China BCG and Tuberculosis Vaccine Sales Quantity Market Share, 2024 VS 2031

Figure 53. by Application, China BCG and Tuberculosis Vaccine Sales Quantity Market Share, 2024 VS 2031

Figure 54. Japan BCG and Tuberculosis Vaccine Sales Quantity, 2020-2031, (K Units)

Figure 55. by Type, Japan BCG and Tuberculosis Vaccine Sales Quantity Market Share, 2024 VS 2031

Figure 56. by Application, Japan BCG and Tuberculosis Vaccine Sales Quantity Market Share, 2024 VS 2031

Figure 57. South Korea BCG and Tuberculosis Vaccine Sales Quantity, 2020-2031, (K Units)

Figure 58. by Type, South Korea BCG and Tuberculosis Vaccine Sales Quantity Market Share, 2024 VS 2031

Figure 59. by Application, South Korea BCG and Tuberculosis Vaccine Sales Quantity Market Share, 2024 VS 2031

Figure 60. Southeast Asia BCG and Tuberculosis Vaccine Sales Quantity, 2020-2031, (K Units)

Figure 61. by Type, Southeast Asia BCG and Tuberculosis Vaccine Sales Quantity Market Share, 2024 VS 2031

Figure 62. by Application, Southeast Asia BCG and Tuberculosis Vaccine Sales Quantity Market Share, 2024 VS 2031

Figure 63. India BCG and Tuberculosis Vaccine Sales Quantity, 2020-2031, (K Units)

Figure 64. by Type, India BCG and Tuberculosis Vaccine Sales Quantity Market Share, 2024 VS 2031

Figure 65. by Application, India BCG and Tuberculosis Vaccine Sales Quantity Market Share, 2024 VS 2031

Figure 66. Middle East & Africa BCG and Tuberculosis Vaccine Sales Quantity, 2020-2031, (K Units)

Figure 67. by Type, Middle East & Africa BCG and Tuberculosis Vaccine Sales Quantity Market Share, 2024 VS 2031

Figure 68. by Application, Middle East & Africa BCG and Tuberculosis Vaccine Sales Quantity Market Share, 2024 VS 2031

Figure 69. Research Methodology

Figure 70. Breakdown of Primary Interviews

Figure 71. Bottom-up Approaches

Figure 72. Top-down Approaches